Halometasone
- Level
- Commodity
- Parent
- 51422300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51422320This classification denotes a betamethasone analog, anti-asthmatic agent, anti-inflammatory agent, and glucocorticoid with the molecular formula C22H27ClF2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J69Z9UU41Z, chemically known as 2-chloro-6alpha,9-difluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione but generally known as halometasone, which bears US NIH Compound Identifier 39745. European Medicines Agency schedules Halometasone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08001MIG. World Health Organization schedules halometasone in its Anatomical Therapeutic Chemical (ATC) Classification. HALOMETASONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule halometasone under HS 29372200 and SITC 54153. As of Q4 2014, HALOMETASONE remains the US FDA Preferred Term for this commodity. SMILES: CLC1=CC2(C3(F)C(C4C(C(O)(C(C4)C)C(=O)CO)(CC3O)C)CC(F)C2=CC1=O)C.
Same parent
Under 51422300 · 70Activities that produce or sell this
KBLI · 9Inherited from family 51420000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.